144 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp02843 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 45% Cytotoxicity at 50 mg/L |
| dbacp02844 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 38% Cytotoxicity at 25 mg/L |
| dbacp02845 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 75% Cytotoxicity at 50 mg/L |
| dbacp02846 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 65% Cytotoxicity at 25 mg/L |
| dbacp02847 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 75 % Cytotoxicity at 50 mg/L |
| dbacp02848 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 65% Cytotoxicity at 25 mg/L |
| dbacp02849 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 83% Cytotoxicity at 50 mg/L |
| dbacp02850 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 77 % Cytotoxicity at 25 mg/L |
| dbacp02851 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 82 % Cytotoxicity at 50 mg/L |
| dbacp02852 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 85 % Cytotoxicity at 25 mg/L |
| dbacp02853 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 42 % Cytotoxicity at 12.5 mg/L |
| dbacp02854 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 41 % Cytotoxicity at 6.25 mg/L |
| dbacp02855 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 39 % Cytotoxicity at 3.125 mg/L |
| dbacp02856 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 90 % Cytotoxicity at 50 mg/L |
| dbacp02857 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 95 % Cytotoxicity at 25 mg/L |
| dbacp02858 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 45 % Cytotoxicity at 12.5 mg/L |
| dbacp02859 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 25 % Cytotoxicity at 6.25 mg/L |
| dbacp02860 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 25 % Cytotoxicity at 3.125 mg/L |
| dbacp02861 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 95 % Cytotoxicity at 50 mg/L |
| dbacp02862 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 96 % Cytotoxicity at 25 mg/L |
| dbacp02863 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 46 % Cytotoxicity at 12.5 mg/L |
| dbacp02864 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 30 % Cytotoxicity at 6.25 mg/L |
| dbacp02865 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 28 % Cytotoxicity at 3.125 mg/L |
| dbacp02866 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 84 % Cytotoxicity at 50 mg/L |
| dbacp02867 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 85 % Cytotoxicity at 25 mg/L |
| dbacp02868 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 38 % Cytotoxicity at 12.5 mg/L |
| dbacp02869 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 30 % Cytotoxicity at 6.25 mg/L |
| dbacp02870 | Epinecidin-1 | GFIFHIIKGLFHAGKMIHGLV | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 28 % Cytotoxicity at 3.125 mg/L |
| dbacp02874 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 60 % Cytotoxicity at 50 mg/L |
| dbacp02875 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 50 % Cytotoxicity at 25 mg/L |
| dbacp02876 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 8 % Cytotoxicity at 12.5 mg/L |
| dbacp02877 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 10 % Cytotoxicity at 6.25 mg/L |
| dbacp02878 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 5 % Cytotoxicity at 3.125 mg/L |
| dbacp02879 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 75 % Cytotoxicity at 50 mg/L |
| dbacp02880 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 70 % Cytotoxicity at 25 mg/L |
| dbacp02881 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 5 % Cytotoxicity at 12.5 mg/L |
| dbacp02882 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 7 % Cytotoxicity at 6.25 mg/L |
| dbacp02883 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 10 % Cytotoxicity at 3.125 mg/L |
| dbacp02884 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 76 % Cytotoxicity at 50 mg/L |
| dbacp02885 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 70 % Cytotoxicity at 25 mg/L |
| dbacp02886 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 12 % Cytotoxicity at 12.5 mg/L |
| dbacp02887 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 4 % Cytotoxicity at 6.25 mg/L |
| dbacp02888 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 4 % Cytotoxicity at 3.125 mg/L |
| dbacp02889 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 90 % Cytotoxicity at 50 mg/L |
| dbacp02890 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 75 % Cytotoxicity at 25 mg/L |
| dbacp02891 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 8 % Cytotoxicity at 12.5 mg/L |
| dbacp02892 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 3 % Cytotoxicity at 6.25 mg/L |
| dbacp02893 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 3 % Cytotoxicity at 3.125 mg/L |
| dbacp02894 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 60 % Cytotoxicity at 50 mg/L |
| dbacp02895 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 50 % Cytotoxicity at 25 mg/L |
| dbacp02896 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 8 % Cytotoxicity at 12.5 mg/L |
| dbacp02897 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 10 % Cytotoxicity at 6.25 mg/L |
| dbacp02898 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 5 % Cytotoxicity at 3.125 mg/L |
| dbacp02899 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 75 % Cytotoxicity at 50 mg/L |
| dbacp02900 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 70 % Cytotoxicity at 25 mg/L |
| dbacp02901 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 5 %Cytotoxicity at 12.5 mg/L |
| dbacp02902 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 7 % Cytotoxicity at 6.25 mg/L |
| dbacp02903 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 10 % Cytotoxicity at 3.125 mg/L |
| dbacp02904 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 76 % Cytotoxicity at 50 mg/L |
| dbacp02905 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 70 % Cytotoxicity at 25 mg/L |
| dbacp02906 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 12 % Cytotoxicity at 12.5 mg/L |
| dbacp02907 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 4 % Cytotoxicity at 6.25 mg/L |
| dbacp02908 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 4 % Cytotoxicity at 3.125 mg/L |
| dbacp02909 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 90 % Cytotoxicity at 50 mg/L |
| dbacp02910 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 75 % Cytotoxicity at 25 mg/L |
| dbacp02911 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 8 % Cytotoxicity at 12.5 mg/L |
| dbacp02912 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 3 % Cytotoxicity at 6.25 mg/L |
| dbacp02913 | Epinecidin-8 | FIFHIIKGLFHAGKMI | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 3 % Cytotoxicity at 3.125 mg/L |
| dbacp05139 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 62 % Cytotoxicity at 50 mg/L |
| dbacp05140 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 44 % Cytotoxicity at 25 mg/L |
| dbacp05141 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 4 % Cytotoxicity at 12.5 mg/L |
| dbacp05142 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 75 % Cytotoxicity at 50 mg/L |
| dbacp05143 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 70 % Cytotoxicity at 25 mg/L |
| dbacp05144 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 4 % Cytotoxicity at 3.125 mg/L |
| dbacp05145 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 78 % Cytotoxicity at 50 mg/L |
| dbacp05146 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 68 % Cytotoxicity at 25 mg/L |
| dbacp05147 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 4 % Cytotoxicity at 12.5 mg/L |
| dbacp05148 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 5 % Cytotoxicity at 6.25 mg/L |
| dbacp05149 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 10 % Cytotoxicity at 3.125 mg/L |
| dbacp05150 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 90 % Cytotoxicity at 50 mg/L |
| dbacp05151 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 80 % Cytotoxicity at 25 mg/L |
| dbacp05152 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 15 % Cytotoxicity at 12.5 mg/L |
| dbacp05153 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 12 % Cytotoxicity at 6.25 mg/L |
| dbacp05154 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 5 % Cytotoxicity at 3.125 mg/L |
| dbacp05155 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 88 % Cytotoxicity at 50 mg/L |
| dbacp05156 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 82 % Cytotoxicity at 25 mg/L |
| dbacp05157 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 40 % Cytotoxicity at 12.5 mg/L |
| dbacp05158 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 35 % Cytotoxicity at 6.25 mg/L |
| dbacp05159 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 35 % Cytotoxicity at 3.125 mg/L |
| dbacp05160 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 90 % Cytotoxicity at 50 mg/L |
| dbacp05161 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 90 % Cytotoxicity at 25 mg/L |
| dbacp05162 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 30 % Cytotoxicity at 12.5 mg/L |
| dbacp05163 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 30 % Cytotoxicity at 6.25 mg/L |
| dbacp05164 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 30 % Cytotoxicity at 3.125 mg/L |
| dbacp05165 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 97 % Cytotoxicity at 50 mg/L |
| dbacp05166 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 95 % Cytotoxicity at 25 mg/L |
| dbacp05167 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 39 % Cytotoxicity at 12.5 mg/L |
| dbacp05168 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 28 % Cytotoxicity at 6.25 mg/L |
| dbacp05169 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 38 % Cytotoxicity at 3.125 mg/L |
| dbacp05170 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 90 % Cytotoxicity at 50 mg/L |
| dbacp05171 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 90 % Cytotoxicity at 25 mg/L |
| dbacp05172 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 15 % Cytotoxicity at 12.5 mg/L |
| dbacp05173 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 5 % Cytotoxicity at 6.25 mg/L |
| dbacp05174 | Pardaxin-1 | GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 10 % Cytotoxicity at 3.125 mg/L |
| dbacp05175 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 70 % Cytotoxicity at 50 mg/L |
| dbacp05176 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 60 % Cytotoxicity at 25 mg/L |
| dbacp05177 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 4 % Cytotoxicity at 12.5 mg/L |
| dbacp05178 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 5 % Cytotoxicity at 6.25 mg/L |
| dbacp05179 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 1 % Cytotoxicity at 3.125 mg/L |
| dbacp05180 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 78 % Cytotoxicity at 50 mg/L |
| dbacp05181 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 70 % Cytotoxicity at 25 mg/L |
| dbacp05182 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 10 % Cytotoxicity at 12.5 mg/L |
| dbacp05183 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 10 % Cytotoxicity at 6.25 mg/L |
| dbacp05184 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 5 % Cytotoxicity at 3.125 mg/L |
| dbacp05185 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 82 % Cytotoxicity at 50 mg/L |
| dbacp05186 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 70 % Cytotoxicity at 25 mg/L |
| dbacp05187 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 18 % Cytotoxicity at 12.5 mg/L |
| dbacp05188 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 4 % Cytotoxicity at 6.25 mg/L |
| dbacp05189 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 10 % Cytotoxicity at 3.125 mg/L |
| dbacp05190 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 90 % Cytotoxicity at 50 mg/L |
| dbacp05191 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 82 % Cytotoxicity at 25 mg/L |
| dbacp05192 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 18 % Cytotoxicity at 12.5 mg/L |
| dbacp05193 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 18 % Cytotoxicity at 6.25 mg/L |
| dbacp05194 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HeLa | Cervical cancer | 18 % Cytotoxicity at 3.125 mg/L |
| dbacp05195 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 80 % Cytotoxicity at 50 mg/L |
| dbacp05196 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 85 % Cytotoxicity at 25 mg/L |
| dbacp05197 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 45 % Cytotoxicity at 12.5 mg/L |
| dbacp05198 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 30 % Cytotoxicity at 6.25 mg/L |
| dbacp05199 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 25 % Cytotoxicity at 3.125 mg/L |
| dbacp05200 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 84 % Cytotoxicity at 50 mg/L |
| dbacp05201 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 84% Cytotoxicity at 25 mg/L |
| dbacp05202 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 48 % Cytotoxicity at 12.5 mg/L |
| dbacp05203 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 30 % Cytotoxicity at 6.25 mg/L |
| dbacp05204 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 35 % Cytotoxicity at 3.125 mg/L |
| dbacp05205 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 90 % Cytotoxicity at 50 mg/L |
| dbacp05206 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 85 % Cytotoxicity at 25 mg/L |
| dbacp05207 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 30 % Cytotoxicity at 12.5 mg/L |
| dbacp05208 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 35 % Cytotoxicity at 6.25 mg/L |
| dbacp05209 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 15 % Cytotoxicity at 3.125 mg/L |
| dbacp05210 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 90 % Cytotoxicity at 50 mg/L |
| dbacp05211 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 90 % Cytotoxicity at 25 mg/L |
| dbacp05212 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 20 % Cytotoxicity at 12.5 mg/L |
| dbacp05213 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 1 % Cytotoxicity at 6.25 mg/L |
| dbacp05214 | Pardaxin-6 | GFFALIPKIISSPLFKTLLSAVGSALS | Brown-lined reefcod | Inducing membrane permeabilization | MTT/MTS assay | HT-1080 | Fibrosarcoma | 10 % Cytotoxicity at 3.125 mg/L |